News from gc pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 30, 2019, 03:37 ET GC Pharma Reports Q1 2019 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended March 31, 2019. Key Figures ...


Apr 15, 2019, 22:57 ET GC Pharma Marks 'World Hemophilia Day'

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, joins World Hemophilia Day, observed annually by the World Federation of Hemophilia (WFH) and the...


Apr 03, 2019, 23:11 ET Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug

Clinigen K.K. and GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280) today announced an exclusive licensing agreement in Japan to commercialize Hunterase (Idursulfase-beta) ICV, a...


Mar 26, 2019, 00:04 ET GCAM Adds New Plasma Collection Center

GCAM, Inc., a U.S.-based plasma collection company, announced that it has added additional plasma collection centers; located in Brownsville, Texas. With the newest additions, GCAM now runs 10 plasma ...


Feb 12, 2019, 09:00 ET GC Pharma Reports Full Year 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2018. Key...


Nov 09, 2018, 03:16 ET GCAM Adds New Plasma Collection Centers

GCAM, Inc., a U.S. based plasma collection company, announced that it has added two additional plasma collection centers; one located in Indianapolis, Indiana, and another in Pasco, Washington. With...


Nov 05, 2018, 10:00 ET Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate

Curevo, a Seattle-based biotechnology company owned by GC Pharma, one of the largest therapeutic protein manufacturers in the world, announced today that the U.S. Food and Drug Administration (FDA)...


Oct 30, 2018, 04:33 ET GC Pharma Reports Q3 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended September 30, 2018. Key...


Aug 01, 2018, 00:24 ET GC Pharma Reports Q2 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended June 30, 2018. Key Figures...


May 20, 2018, 19:00 ET GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. ("Curevo"). The newly established...


Apr 27, 2018, 04:10 ET GC Pharma Reports Q1 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended March 31, 2018. Key Figures ...


Apr 16, 2018, 08:00 ET GC Pharma Marks 'World Haemophilia Day'

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, joins World Haemophilia Day; observed annually by the World Federation of Haemophilia (WFH) and the...


Feb 13, 2018, 23:13 ET GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical ...


Feb 04, 2018, 21:46 ET GC Pharma Reports Full Year 2017 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2017. Key Figures Full...